𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part

✍ Scribed by Vermorken, J B; Guigay, J; Mesia, R; Trigo, J M; Keilholz, U; Kerber, A; Bethe, U; Picard, M; Brummendorf, T H

Book ID
109838775
Publisher
Nature Publishing Group
Year
2011
Tongue
English
Weight
251 KB
Volume
104
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

8517 Phase I results from an open-label,
8517 Phase I results from an open-label, randomized, controlled, phase I/II study (ADVANTAGE) to evaluate the combination of different cilengitide regimens with cisplatin, 5-FU, and cetuximab in patients with recurrent/metastatic squamous cell cancer of the head and neck (SCCHN)
✍ BrΓΌmmendorf, T.; Guigay, J.; MesΓ­a, R.; Trigo, J.; Keilholz, U.; Dittrich, C.; K πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 72 KB
A phase II trial of cisplatin and vinore
A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
✍ Enrique Espinosa; Pilar Zamora; Alfredo MillΓ‘; Serafin Morales; Raquel Molina; M πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv